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Abstract 
The effect of thiol/disulfide xchange on ATP-dependent S-(2,4-dinitrophenyl)glutathione (GS-DNP) transport was studied in sodium 
nitrate treated rat liver plasma membrane vesicles. Transport followed Michaelis-Menten kinetics with an apparent K m of 9.6 /xM for 
GS-DNP and 124/~M for ATP. 5,5'-Dithiobis(2-nitrobenzoate) (DTNB) and N-ethylmaleimide (NEM) efficiently inactivated GS-DNP 
transport activity in a dose- and time-dependent manner. Half-maximal inactivation occurred in 10 min at 40 p~M for DTNB and 550/xM 
for NEM. Inactivation by DTNB was reversed by dithiothreitol. S-(N-Ethyl)maleimyl glutathione and/or ATP-Mg 2÷, but neither 
S-(N-ethyl)maleimyl cysteinylglycine nor oxidized glutathione could protect ransport activity from inactivation by NEM or cystamine. 
These results suggest that reactive thiols are located near the active site of the transporter and that S-alkyl and the y-glutamyl residues of 
glutathione are important for protection. Biological disulfides which were tested included cystine, oxidized glutathione, oxidized 
Coenzyme-A, oxidized lipoic acid, and oxidized lipoamide; cystamine was the most potent reversible inactivator. Molecular oxygen also 
inactivated transport activity, which was recovered on addition of dithiothreitol, suggesting intramolecular disulfide formation by vicinal 
thiols. We interpret these results to indicate that the ATP-dependent GS-DNP transporter contains two or more thiols which are necessary 
for the maintenance of transport activity. The reversible inactivation of the activity by biological disulfides uggests that the transporter 
may be regulated by thiol/disulfide xchange in vivo. 
Keywords: Glutathione conjugate; ATP-dependent transport; Sulfhydryl modification; (Rat liver) 
I. Introduction 
Glutathione (GSH) ~ has many important functions in 
cells: maintenance of the cellular redox state providing 
protection from oxidative stress, metabolic regulation of 
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protein function by thiol/disulfide xchange, biosynthesis 
of physiologically active substances, and detoxification of 
nucleophilic compounds, including heavy metals [1-8]. 
Previous investigations demonstrated that GS-conjugates 
are eliminated from cells by an ATP-dependent process in 
various tissues and organisms, including yeast and plants 
[9-19]. This transporter effiuxes not only GS-conjugates, 
but also bromosulfophthalein, glucuronide- or taurine-con- 
jugates and other divalent anions [20-23]. In hepatocytes, 
the transporter is located in the bile canalicular domain of 
the plasma membrane and is important in transporting 
various organic anions out of the cell. TR-  rats lack this 
function in liver, but not in erythrocytes [10,21,24-26], 
indicating that there may be several gene products or that 
there are tissue-specific differences in regulation or gene 
expression. 
Recently, two candidates have been proposed as GS- 
DNP transporters in mammalian cells. The first is the MRP 
I (multidrug resistance-associated protein) gene product, a 
190 kDa protein which is a member of the ATP-binding 
36 Y. Matsuda et al. / Biochimica et Biophysica Acta 1279 (1996~ 35-42 
cassette (ABC-type) transport family of proteins [27]. This 
protein has been identified as a glutathione S-conjugate 
transporter in several tumor cell lines exhibiting multidrug 
resistance in the absence of MDR1 overexpression a d in 
normal cells following transfection with the MRP1 gene 
and overexpression f the MRP1 protein [27-29]. How- 
ever, as determined by Northern blot analysis, MRPI 
expression in normal human liver was not detected [30]. 
Barely detectable xpression was observed by an RNAse 
protection assay [31]. A second candidate transporter was 
purified by ATP and GS-DNP affinity chromatography 
from liver plasma membrane detergent extracts by Zimniak 
and colleagues [32,33]. This protein has an apparent 
molecular mass of 90 kDa and does not appear to be an 
ABC-type protein. 
In an effort to characterize structural requirements of 
the transporter which are necessary for its activity, we 
initiated studies into the effects of reversible and irre- 
versible sulfhydryl modification reagents on bile canalicu- 
lar ATP-dependent GS-DNP transport. 
2. Materials and methods 
2.1. Plasma membrane vesicle preparation from rat liters 
resuspended in a minimum volume'of THG buffer and 
stored at -80°C until used. 
2.2. Transport studies 
ATP-dependent transport of GS-DNP into NO3LMVs 
was measured by a rapid filtration method as described, 
previously [22,23]. GS-DNP uptake in the absence of ATP 
was subtracted from that in the presence of ATP. Unless 
otherwise stated, the standard reaction mixture contained 
NO3LMVs (1.5-2.5 mg/ml), 6 /~M [glycine-2-3H]GS - 
DNP, 4 mM MgSO~ ___ 4 mM ATP/Tris and an ATP-re- 
generating system (10 mM creatine phosphate and 25 
U/ml creatine kinase) in THG buffer (pH 7.4) at 37°C. 
Transport was started by adding NO3LMVs and stopped at 
the appropriate time by diluting into 1 mi of ice-cold THG 
buffer. The diluted mixture was passed through a What- 
man GF/C  glass filter (1.2 /~m pore size); membranes 
were washed with 6 ml of ice-cold THG buffer. Radioac- 
tivity on the dried filter was soaked in Ready Safe TM 
(Beckman) and measured using a liquid scintillation counter 
(Beckman LS-1801). 
2.3. Modification of reactire thiols by L'arious sulfhydryl 
reagents and ox3'gen species 
Liver plasma membrane vesicles were prepared from 
male Wistar rats (200-300 g), using the third pellet as 
described by Ray [34] followed by sodium nitrate treat- 
ment. Briefly, dissected liver from anesthetized rats was 
perfused with ice-cold saline to remove erythrocytes, and 
scraped on ice while adding 10 mg/g liver tissue of 
phenylmethylsulfonyl fluoride as a proteinase inhibitor. 
The scraped liver tissue was homogenized with a Dounce 
loose pestle (25 strokes) and diluted 100-times the wet 
weight with cold 1 mM sodium bicarbonate containing 0.5 
mM CaC12 (pH 7.8), and allowed to stand for 10 min. The 
diluted homogenate was filtered through six layers of 
cheesecloth and centrifuged at 3000 rpm for 30 min with- 
out brake at 4°C using a Beckman JA14 rotor. This first 
pellet was saved and gently homogenized (five strokes). 
The suspension was diluted to half the previous volume 
(50-times) and centrifuged at 2500 rpm for 20 min at 4°C. 
Only the fluffy pellet was collected (the second pellet), 
homogenized again with five gentle strokes, and cen- 
trifuged as above. The fluffy pellet was saved and cen- 
trifuged at 25 000 rpm for 30 min at 4°C using a Beckman 
45 Ti rotor. The resulting pellet (designated as the third 
pelle0 was resuspended at 1 mg protein/ml in 20 mM 
Tris-Hepes/10% glycerol (THG) buffer (pH 7.4), contain- 
ing 0.5 M NaNO 3, 1 mM EDTA and 1 mM benzamidine. 
The mixture was gently stirred at room temperature for 60 
min and ultracentrifuged as above. The pellet was washed 
(at least 100-times dilution) twice with THG buffer and 
centrifuged as above. The pellet designated as sodium 
nitrate treated liver membrane vesicles (NO3LMVs) was 
NO3LMVs (2-4 mg/mi) were incubated at 25°C for 
various times in various concentrations of sulfhydryl 
reagents and oxygen species in 0.3-0.6 ml degassed THG 
buffer containing 0.5 mM EDTA. The incubation buffer 
was prepared at pH 7.4 for dithiobis(2-nitrobenzoate) 
(DTNB) and 2-nitrothiocyanobenzoate (NTCB), pH 7.2 for 
N-ethylmaleimide (NEM) and pH 8.0 for biological disul- 
fides. The pH of all reagents was adjusted with Tris base 
just before use. Reactions were started by adding sulfhydryl 
reagents to the NO3LMVs and stopped by diluting the 
mixture with 25 ml of ice-cold degassed THG buffer 
containing 1 mM EDTA. The diluted mixture was cen- 
trifuged at 25 000 rpm (Beckman 60 TI rotor) for 30 min. 
After washing once with 25 ml of THG buffer, the pellet 
was resuspended in 1 ml buffer and microfuged at 14000 
rpm for 10 rain. The resulting pellet was resuspended to
150-200/.d of THG buffer (pH 7.4) and immediately used 
for transport studies. Some mixtures were further treated 
with 10 mM D'lq" for 30 min at 25°C before the dilution- 
centrifugation procedure. In case of longer incubation with 
GSSG or cystine for 16 h at 4°C, 0.5 ml of NO3LMVs (4.0 
mg/ml) were dialyzed against 500 ml of degassed THG 
buffer, 1 mM EDTA (pH 7.4) containing 0.5 mM GSSG 
and 1 mM cystine. The resulting mixture was extensively 
dialyzed in THG buffer containing 1 mM EDTA to re- 
move excess unreacted sulfhydryl reagent changing buffer 
three times every 3 h. Treatment with 10 mM DTT was 
undertaken by dialysis with THG buffer containing 1 mM 
EDTA and DTr  for 3 h before extensive dialysis. 
Oxidation of NO3LMVs (2.0 mg/ml) by oxygen species 
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was performed in 0.6 ml degassed THG buffer (pH 7.4) 
containing 50 /zM CuSO 4, for 20 min. We used hydrogen 
peroxide (HzO 2) alone or with catalase (56 U/ml)  to 
generate molecular oxygen. The reaction was started by 
adding H20 z at room temperature. After 20 min, the 
mixture was incubated with or without 10 mM DTT for an 
additional 30 min, and then subjected to the dilution-cen- 
trifugation procedure as described. To calculate H202 
concentration, the molar extinction coefficient (43.6 M-  
cm-l  at 240 nm) for hydrogen peroxide was used [35]. 
was greater than 95% as assessed by HPLC. S-(N- 
ethyl)maleimyl conjugates of GSH, cysteinylglycine 
(Cys(Gly)) and cysteine (Cys) were non-enzymatically 
synthesized by co-incubation with reduced GSH and NEM, 
Cys(Gly) and NEM, and Cys and NEM, respectively, as 
described in [18]. The extent of conjugation was monitored 
using DTNB to detect he amount of free sulfydryl remain- 
ing in the reaction mixture [40]. Reverse-phase HPLC was 
used to check the purity of all conjugates. 
2.4. Protection of reactive thiols from NEM and cystamine 3. Results 
NO3LMVs (2.2 mg/ml)  were preincubated at 25°C 
with 10 mM of various protectants in 0.6 ml degassed 
THG buffer containing 0.5 mM EDTA (pH 7.2), and 10 
min later, the sulfhydryl reaction was started by adding 
NEM (0.4 mM); 60 min later, it was stopped by diluting 
the mixture into 25 ml of ice-cold THG buffer and centri- 
fuging as described (vide supra). 
2.5. Enzyme and protein assays 
Mg2+-ATPase, Na+,K+-ATPase, leucJne aminopepti- 
dase (LAP) and y-glutamyltranspeptidase (y-GTP) activity 
served as marker enzymes and were assayed [36-38]. 
Protein concentration was measured by the method of 
Bradford [39], using bovine serum albumin as a standard. 
2.6. Chemicals and biochemicals 
[glycine-2-3H]Glutathione (43.8 Ci/mmol) was pur- 
chased from Du Pont-New England Nuclear. Other chemi- 
cals and biochemicals of reagent grade were obtained from 
Sigma. Sulfhydryl reagents were prepared immediately 
prior to use. All other reagents were prepared as greater 
than 10 × concentrated stock solutions, and the pH was 
adjusted before dilution. 
[3H]GS-DNP was synthesized from [glycine-2- 
3H]glutathione and l-chloro-2,4-dinitrobenzene zymati- 
cally using glutathione S-transferase as described [9]. The 
recovery of radioactive product was about 80% and purity 
3.1. Characterization of NO~ LMVs 
Canalicular marker enzymes, LAP, T-GTP and Mg 2+- 
ATPase, were enriched 3-6-fold in crude liver plasma 
membrane (Ray's third pellet) with respect o homogenate 
(Table 1). Enrichment of Na+,K+-ATPase, a sinusoidal 
marker enzyme, was less than half. Mg 2+ 
ATPase/Na+,K+-ATPase activity ratio increased 7.2-fold 
from 1.2 to 8.6. Cytochrome oxidase was slightly contami- 
nating, but lactate dehydrogenase was not detected even 
after sonication (data not shown). These data agree with 
prior characterization f canalicular membranes [41]. Al- 
though Ray's third pellet is still crude, it contained ATP- 
dependent GS-DNP transport activity (2.51 +_ 2.03 
pmol /mg per min). To obtain higher activity, we tried to 
remove superficially or loosely bound proteins by treat- 
ment with chaotropic reagents including NaSCN, KI, 
NaNO 3 and NaCIO 4. Treatment with 0.5 M NaNO 3 for 60 
min was the best, resulting in 8-fold higher specific activ- 
ity and 3-fold increase in total activity, which might be 
responsible for removal of endogenous inhibitors against 
transport system. Transport activity was retained in 
NO3LMVs, suggesting that the GS-DNP transporter is 
associated tightly with the plasma membrane. Protein re- 
covery as NO3LMVs was 97.7 + 25.6 mg (about 1.8% of 
total homogenate protein) from 40 g of rat liver. 
ATP-mediated GS-DNP uptake increased in a time- and 
dose-dependent manner showing linear uptake for 4 min 
(Fig. la). Transport was saturable (Fig. lb and Fig. lc). 
Table 1 
Protein recovery and activity of ATP-dependent GS-DNP transport and marker enzymes 
Homogenate 3rd pellet 3rd pellet reated with NaNO 3 
5.48 + 1.1 g 231 +49.6 mg 97.7 ± 25.6 mg 
2.53 ± 2.03 19.6 ± 5.63 
- 580 = 1920 
Protein from 40 g wet liver 
Transport activity (pmol/mg per min) 
Total activity (pmol/min) 
nmol/min per mg protein 
Mg2+-ATPase 151 +44 483 ±32 591 +76 
Na+,K+-ATPase 130 ±26 56 + 3.5 43 + 1.9 
Leucineaminopeptidase 16 ± 3.1 50 ± 4.0 105 + 6.1 
",/-Glutamyltransferase 0.9 + 0.29 5.4 + 0.4 19.3 + 6.7 
All values are measured asdescribed inMaterials and methods and represent the means +S.D. from four separate experiments. 
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The apparent K m values were 9.6 /xM and 124 p.M for 
GS-DNP and ATP, respectively, which are similar to the 
previous values reported by Kobayashi et al. [12]. As 
shown in Table 2, hydrolyzable phosphorus in the y-posi- 
tion was required for GS-DNP transport (ADP, AMP and 
AMPPCP were 19, 9 and 5% of control, respectively) in a 
vanadate-inhibitable fashion (37% of control in 0.1 mM 
orthovanadate). ATP was specifically required, since AM- 
PCPP (37%), GTP (16%), UTP (17%) and CTP (32%) 
were poor energy sources for GS-DNP transport as previ- 
ously demonstrated [9,12,18,19,23]. GS-DNP and GS-NEM 
(0.1 mM each) inhibited ATP-dependent [3H]GS-DNP up- 
take to 29% and 74%, respectively as compared to con- 
trols. Cys(Gly)-NEM (93%), Cys-NEM (105%), GSSG 
(87%) and GSH (105%) were not good inhibitors, possibly 
due to lack of an S-alkyl moiety at cysteine and/or 
y-glutamyl residue of GSH. 10 mM GS-NEM completely 
inhibited transport activity, whereas 10 mM GSSG inhib- 
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Fig. 1. Time course of GS-DNP uptake and effect of GS-DNP/ATP on 
ATP dependent GS-DNP transport by sodium nitrate treated liver mem- 
brane vesicles (NO3LMVs) (a) NO3LMVs (560 ~g) were incubated for 
appropriate time at 37°C with 5/xM [3H]GS-DNP in the presence (0 )  or 
absence (O)  of 4 mM ATP/Tris in 280 /xl of buffer containing 20 mM 
Tris/Hepes, 10% glycerol, 4 mM MgSO 4, 10 mM phosphocreatine and 
100 mg/ml  creatine kinase (pH 7.4) (buffer A). (b) NO3LMVs (560/xg) 
were incubated at 37°C for 4 min with various concentration of [3H]GS- 
DNP in 280 /xl of buffer A in the presence or absence of 4 mM 
ATP/Tris. (c) NO3LMVs (560 /xg) were incubated at 37°C for 4 min 
with various concentration of ATP/Tris and 6 /,tM [3H]GS-DNP in 280 
/zl of buffer A. Vesicle-associated GS-DNP uptake and ATP-stimulated 
GS-DNP transport were determined as described under Materials and 
methods. All values represent the mean of duplicates in two separate 
experiments. 
Table 2 
Effects of various nucleotides, GSH derivatives, vanadate, taurocholate 
and daunomycin on ATP-dependent GS-DNP transport in NaNO3-treated 
plasma membrane vesicles 
Relative transport activity ¢ 
(raM) (%) Nucleotide specificity a 
ATP 
GTP 
UTP 
CTP 
ADP 
AMP 
AMPPCP 
AMPCPP 
Inhibitory effect b 
Control (22.3 pmol /mg per rain) 
GSH 
GSSG 
GS-DNP 
GS-NEM 
Cys(Gly)-NEM 
Cys-NEM 
Orthovanadate 
Taurocholate 
Daunomycin 
5.0 100 
5.0 16 
5.0 17 
5.0 32 
5.0 19 
5.0 9 
5.0 5 
5.0 37 
100 
0.1 142 (104, 181) a 
0.1 87 (93, 81) a 
10.0 50 
0.1 29 
0.1 74(80,71) a
5.0 35 
I0.0 0 
0.1 93 (92, 94) a 
0.1 105 
(/~M) (%) 
100 37 
50 9 I 
50 109 
a NO3LMV s (2.0 mg/ml)  were incubated at 37°C for 2 min in THG 
buffer (pH 7.4), 5 mM MgSO 4, 6 #M [3H}GS-DNP, +5 mM various 
nucleotides in the absence of creatine kinase and phosphocreatine. 
b In the presence of the indicated substrates, ATP-dependent GS-DNP 
transport activity was measured under standard conditions as described in 
Materials and Methods, except for 88 pM [3H]GS-DNP. 
c Values represent mean of % control activities from duplicate determina- 
tions. 
a Indicates the values from two separate preparations shown in parenthe- 
ses. 
ited only 50%. Taurocholate and daunomycin were poor 
inhibitors, confirming that the GS-DNP transporter is dis- 
tinct from those responsible for taurocholate and dauno- 
mycin transport [9,12,21,23,42-44]. ATP-dependent auro- 
cholate transport was also found in NO3LMVs (41.3 
pmol/mg per min at 4.8 /zM taurocholate) and was as 
high as in purified canalicular membrane vesicles [42-44]. 
NO3LMVs also contained immunoreactive p-glycoprotein 
which reacted with antibody C219 (purchased from CEN- 
TOCOR, Malvern, PA) by Western blotting (data not 
shown) [45]. 
3.2. Effect of chemical sulfhyd~l reagents and oxy. gen 
species on ATP-dependent GS-DNP transport 
ATP-dependent GS-DNP transport was inactivated by 
DTNB and NEM in a dose- and time-dependent manner 
(Fig. 2a and Fig. 2b), with half-maximal inactivation con- 
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centrations at 10 min of 40 p~M and 550/xM, respectively. 
Complete inactivation was accomplished at 1.2 mM DTNB 
and 5 mM NEM in 10 min. Inactivation by DTNB was 
reversible on addition of 10 mM DTT; reactivation was 
75% and 95% of the original activity in 10 and 60 min, 
respectively. These results suggest that the transporter may 
contain reactive thiols, modification of which diminishes 
transport ability. Similarly, NTCB, which creates the S-CN 
moiety, effectively decreased transport activity to 21%. 
Complete recovery of activity occurred following treat- 
ment with DTT (Table 3). 
Molecular oxygen has a bi-directional oxidative func- 
tion. On reaction with thiol as an oxygen donor, it pro- 
duces irreversible sulfenic, sulfinic or sulfonic (cysteic) 
residues, whereas, if reacted as a dehydrant, it creates 
reversible intra- or intersubunit disulfides with adjacent 
thiols [46,47]. Molecular oxygen generated from H202 
with catalase (56 U /ml )  inactivated transport activity to 
26% and 0.4% using 4 and 6 mM H202, respectively 
(Table 3). The oxidized transporter was partly reactivated 
with DTT, which suggests that a disulfide linkage had 
been created. Low recovery of activity implies that some 
; 
l -  60 
WQ: 
¢Z:O 
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10 .4 10-3 10-2 10-~ 1~o ~'~ 
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Table 3 
Modification of reactive thiols of GS-DNP transporter by chemical 
sulfhydryl reagents, biological disulfides and oxygen species 
Compounds Time Residual ATP-dependent GS-DNP 
transport activity (%) a 
mM (min) DTT treated 
Chemical reagents 
DTNB 1.0 10 5.2 105 
NTCB 1.0 10 21 (31, 13) b 109 (100, 118) b 
NEM 1.0 10 20 15 
Biological disulfides 
GSSG 0.5 16 h 41 96 
1.5 90 82 
10.0 60 86 
Cystine 0.2 30 98 
1.0 16 h 43 123 
Cystamine 0.5 60 45 
2.0 60 19 70 
CoASSCoA 0.6 90 79 
Lipoic acid 0.5 60 96 
(oxidized) 2.0 60 80 
Lipoamide 0.5 60 100 
(oxidized) 2.0 60 100 
Oxygen species 
H20.~ 4 20 90 102 
6 20 83 84 
H202/catalase 4 20 26 69 
6 20 0.4 20 
Methods of sulfhydryl modification, subsequent DTI" treatment and 
ATP-dependent GS-DNP transport assay were described inMaterials and 
methods.The incubation time for transport was 4 min. 
a Values represent mean of % control activities from duplicate determina- 
tions. 
b Indicates the values from two separate preparations shown in parenthe- 
ses. 
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Fig. 2. Inactivation f ATP-dependent GS-DNP transport by sulfhydryl 
reagents and effect of dithiothreitol (DTT). (a) Sodium nitrate treated 
liver membrane v sicles (NO3LMVs) (2 mg/ml) were incubated with 
various concentration of DTNB (O) and NEM (11) at pH 7.4 and 7.2, 
respectively, for 10 min in 20 mM Tris/Hepes, 10% glycerol (THG) 
buffer containing 0.5 mM EDTA at room temperature. (b)NO3LMVs 
(4.3 mg/ml) were incubated with 0.1 mM (O), 0.4 mM (O) DTNB and 
0.4 mM (n), 1.6 mM (11) NEM for indicated time in 20 mM THG 
buffer containing 0.5 mM EDTA at room temperature. The pH of 
reaction mixture was 7.4 for DTNB and 7.2 for NEM. 10 mM DTT was 
added at 30 min to the mixture of both 0.4 mM DTNB and 1.6 mM 
NEM. All reactions were stopped by dilution and centrifugation method 
and ATP-dependent GS-DNP transport was assayed at37°C for 4 min. as 
described in Materials and methods. All values represent the mean of 
duplicates intwo separate experiments. 
reactive thiols were irreversibly oxidized to sulfonic acid 
or that oxidation occurred on other amino acids [48] 
essential for transport. These results imply that the GS-DNP 
transporter contains at least two reactive thiols. Hydrogen 
peroxide alone slightly inactivated the transport activity (4 
and 6 mM H202 were 90 and 83% of controls, respec- 
tively), suggesting that oxygen is a more efficient oxidant 
of the GS-DNP transporter than is hydrogen peroxide 
alone. 
3.3. Protection of  reactive dithiols of  the transporter 
If reactive thiols are located near the active site, trans- 
port activity should be protected from thiol oxidation in 
the presence of substrates. We determined whether GS- 
NEM, GSSG and ATP could protect the GS-DNP trans- 
porter against sulfhydryl modification. ATP /Mg 2+ pro- 
tected the transporter f om NEM inactivation (90%), but 
neither ATP (9%) nor Mg 2+ (13%) protected (Table 4), 
suggesting that a conformational change of ATP by Mg 2+ 
[49] is critical for binding to the catalytic site in addition to 
protecting reactive thiols. GS-NEM alone or with 
ATP /Mg 2+ protected transport activity against NEM and 
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Table 4 
Protection of GS-DNP transport activity from NEM and cystamine 
usingspecified substrates 
Restored activity (%) 
Control (15 pmol/mg per min) 100 
0.4 mM NEM, no addition 17 (13,20) a 
+ ATP 9 
+ MgSO 4 13 
+ATP+MgSO 4 90 (83,97) a 
+ GS-NEM 108 
+ GS-NEM + ATP + MgSO 4 102 
+ Cys(GIy)-NEM 8 
+GSSG 12 (9,15) a 
+ GSSG + ATP 27 
+ GSSG + ATP + MgSO 4 57 
+ 0.5 M KC1 8 
5 mM cystamine, no addition 11 
+ ATP + MgSO 4 99 
NO3LMVs (2.2 mg/ml) were preincubated for 10 min with various 
transporter substrates atpH 7.4. Sulfhydryl modifications were started by 
adding NEM or cystamine and reactions were stopped after 60 rain as 
described in Materials and methods. Transport was performed as de- 
scribed in Table 2. The incubation time was 4 min. All protective agents 
added are 10 mM except for KC1. Values represent mean of c~ control 
activities from duplicate determinations. 
a Indicates the values from two separate preparations shown in parenthe- 
ses. 
preserved activity 108% and 102%, as compared with 
controls. However, Cys(Gly)-NEM, which lacks the 3'- 
glutamyl residue of GS-NEM, did not protect (8% protec- 
tion). These results indicate that reactive dithiols and the 
3,-glutamyl residue of GSH conjugates may interact. 0.5 M 
KC1 alone did not protect ransport activity. Surprisingly, 
GSSG, which has been thought o be a substrate of the 
GS-DNP transporter [9,12,13], did not protect transport 
activity, with or without ATP (15% or 27%, respectively). 
This result is consistent with the weak ability of GSSG to 
inhibit GS-DNP transport (Table 2) and suggests that the 
weak binding of GSSG to the transporter may be due to 
lack of an S-alkyl moiety of GSH. Coincubation of GSSG 
and ATP/Mg 2+ showed 57% protection from inactivation 
by NEM. 
3.4. Effect of biological disulfides on ATP-dependent GS- 
DNP transport 
Reactive thiol residues of a protein can form mixed 
disulfides with endogenous biological disulfides in vivo 
resulting in altered function [2,3]. Several biological disul- 
fides were added to NO3LMVs as sulfhydryl reagents. 
Treatment with 0.5 and 2.0 mM cystamine for 60 min 
reversibly decreased GS-DNP transport activity to 45% 
and 19% of control, respectively (Table 3). Among the 
biological disulfides tested, cystamine was the best in- 
hibitor. Incubation for up to 90 min with GSSG, Coen- 
zyme A (oxidized form) and lipoic acid (oxidized form) 
moderately inactivated GS-DNP transport to approx. 82%, 
79% and approx. 80% of controls, respectively, and both 
cystine and lipoamide (oxidized form) showed no effect on 
transport activity. However, prolonged exposure (16 h) to 
0.5 mM GSSG and 1 mM cystine significantly reduced 
transport activity to 41% and 43%, respectively; subse- 
quent treatment with 10 mM D'IT resulted in total recov- 
ery of activity. These findings suggest that biological 
disulfides may be potent inactivators of ATP-dependent 
GS-DNP transport in vivo, most likely due to their ability 
to produce protein-mixed disulfides. 
4. Discussion 
In this report, we characterized an ATP-dependent GS- 
DNP transport activity in NO3LMVs which has require- 
ments similar to those described for the ATP-dependent 
GS-DNP transporter in the canalicular membrane [11- 
13,23,50]. The increase in the specific activity of transport 
in the NO3LMV preparation correlates with the enrich- 
ment of canalicular enzymes, suggesting that the trans- 
porter resides in the canalicular membrane. ATP-depen- 
dent GS-DNP transport in NO3LMVs requires hydrolyz- 
able 3,-phosphate and steric configuration of ATP because 
other nucleotides, including ATP analogs, result in poor 
transport activity [9,12,13,18,19]. Lack of an S-alkyl moi- 
ety (GSSG) and the ",/-glutamyl residue (Cys(GIy)-NEM, 
Cys-NEM) of GSH results in little inhibition of GS-DNP 
transport, which was confirmed by protection study of 
thiois against NEM (Table 4). Therefore, the binding 
affinity of GSSG [9,12,13,18], Cys(Gly)-NEM, and Cys- 
NEM may be lower than that of GS-DNP or GS-NEM. 
The results of thiol modification suggest hat the GS- 
DNP transporter has thiols which are sensitive to sulfhydryl 
reagents and can be modified in a dose- and time-depen- 
dent manner (Fig. 2a and Fig. 2b and Table 3). Inactivation 
by DTNB, NTCB and biological disulfides was reversed 
on addition of DTT. In addition, oxygen gas flushing (1 
L/min for 1 min) of NO3LMV suspensions also decreased 
the transport activity by about 50%, whereas nitrogen gas 
flushing did not (data not shown). Reversible inactivation 
with molecular oxygen indicates that the transporter has 
two or more reactive thiols which can form a disulfide 
linkage (Table 3). Kondo et al. [14] and Akerboom et al. 
[51 ] reported that ATP-dependent GS-DNP transport activ- 
ity was increased by D'Iq" or GSH treatment, which might 
be due to reactivation of the transporter which had been 
already oxidized by atmospheric oxygen (autooxidation) 
during vesicle preparation. This evidence suggests that 
prevention of autooxidation of the GS-DNP transporter 
should minimize loss of the activity during preparation of 
canalicular membrane vesicles and purification of the 
transporter. In this study, all buffers containing EDTA 
were degassed by helium bubbling and excess of sulfhydryl 
reagent was carefully removed prior to GS-DNP transport 
assay. Creatine kinase in the assay mixture is also very 
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sensitive to such reagents [52]. GS-DNP (GSSG) transport 
activity in canalicular membrane vesicles [13] including 
NO3LMVs is more sensitive to inactivation by sulfhydryl 
reagents than is erythrocyte activity [14,15,51,53], which 
may reflect cell-specific differences in gene expression. 
This is supported by studies using TR-  mutant rats which 
lack hepatocyte ATP-dependent GS-DNP transport activity 
but retain similar transport in erythrocytes [25]. 
Lack of ATP/Mg 2+ configuration and absence of an 
S-alkyl moiety or 7-glutamyl residue of GSH resulted in 
poor protection against NEM inactivation, suggesting that 
reactive thiols are important for interaction with substrates 
which have high binding affinity (Table 4). These data also 
suggest that the binding sites for ATP/Mg 2+ and GS-DNP 
are close to each other, since ATP/Mg 2+ and GS-DNP 
protect independently, not additively, against the same 
reactive thiols. 
There is evidence to suggest that cysteine-thiols are 
important for transport activity. The reactive Cys 384 of the 
mannitol transporter must be phosphorylated for uptake of 
mannitol into the cell. Modification of Cys 384 causes the 
transporter to lose its activity [54]. For the proline carrier 
of E. coli ,  modification of cysteine by NEM inhibits 
transport activity. Additionally, substrates can protect his 
cysteine from modification and preserve activity [55]. Fur- 
thermore, several studies utilizing NEM, NBD-C1 and 
HgC12 suggest hat cysteines are important for both the 
transport [56] and ATPase activities of p-glycoprotein [57- 
59], and that ATP can protect against inactivation by NEM 
[58]. More important is the location of a conserved cys- 
teine residue in the 'Walker homology A domain' of 
human MRP1, MDR1 and MDR2 and all hamster p-glyco- 
proteins (personal observation) [57]. Conservation of this 
cysteine suggests that it may be critical for transport and 
ATPase activities. However, other studies indicate that 
cysteines are not essential for activity, but may be impor- 
tant for protein stability or folding. Loo and Clarke created 
a cysteine-less mutant of human MDR 1 and transfected 
the gene into NIH 3T3 cells [60]. Mutation of all cysteines 
to alanines led to a slight decrease in drug resistance, as 
determined by cell viability. They concluded that cysteine 
residues are not essential for MDR 1 activity, but are 
important for protein stability, because the cysteine-less 
protein was glycosylated more slowly and had a shorter 
half-life. However, because they did not measure the func- 
tional activity of the protein, i.e., drug efflux or drug- 
stimulatable ATPase activity, it is not possible to compare 
their results directly with those of A1-Shawi et al. [57-59]. 
The identification of two different gene products as 
ATP-dependent GS-conjugate fflux pumps [27-29,32,33] 
indicates that there is likely to be more than one ATP-de- 
pendent, canalicular GS-conjugate transporter. The present 
study shows that thiol modification of the transporter 
diminished transport activity. However, whether these thi- 
ols are essential for substrate (GS-DNP) transport and/or 
binding remains to be elucidated. 
Recently, Feng and Forgac proposed an endogenous 
activation/ inactivation model of clathrin-coated vesicle 
H+-ATPase by switching disulfide linkages in which 
Cys532-Cys 277 is the active form and Cys532-Cys 254 is the 
inactive form [61]. It will be of interest o see whether the 
GS-DNP transporter can be regulated by this type of 
switching or whether other biological factors cause 
thiol/disulfide xchange. There are many potential regu- 
lating factors for thiols, such as altered cytoplasmic redox 
state caused by exogenous ignals including oxidative 
stress, thiol modification by biological disulfides, and en- 
zymatic disulfide exchange by protein disulfide isomerase 
or thioltransferase [1-3]. Biological disulfides and oxygen 
species decrease ATP-dependent GS-DNP transport activ- 
ity in a manner similar to their effects on other cytosolic 
enzymes. Among biological disulfides, cystamine, a 
metabolic intermediate of taurine synthesis from cysteine, 
was the best inhibitor of the GS-DNP transport activity. In 
addition, reactive oxygen is a potent inactivator that is 
generated uring oxidative stress and as a result of normal 
cellular aerobic metabolism [62]. These observations sug- 
gest that functional regulation of ATP-dependent GS-DNP 
transport by thiol/disulfide xchange may occur in vivo. 
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